● 기업단신
Verizon — Verizon shares slipped 1.51% after the company posted mixed results for the 2022 fourth quarter. While earnings met analyst predictions, forward earnings fell short of a Refinitiv consensus estimate. .
Bed Bath & Beyond — The meme stock gained 5.78%, building on its dramatic start to the year, even as the retailer warns of a potential bankruptcy. Year to date, Bed Bath & Beyond shares are up 17.1%.
Lyft — The ride-sharing stock gained 3.4% following an upgrade from KeyBanc, which Lyft should feel positive impacts from cost-saving measures including layoffs and a stabilization in demand.
Johnson & Johnson — Shares of the drug maker ticked higher by less than 1% premarket after the company reported mixed quarterly financial results. Johnson & Johnson beat profit estimates by 10 cents per share, excluding items, according to Refinitiv. It also missed revenue estimates. Its full-year outlook for earnings was slightly higher than estimates while its revenue forecast was about in line with estimates.
Blackstone — Shares rose 1.3% after JPMorgan upgraded Blackstone to overweight from neutral, saying the investment management firm is a “best in class” business that’s set for a soft landing.
Lululemon — The athleisure retailer fell 2.07% after Bernstein downgraded the stock, warning that a reset is coming for the apparel stock and noting the company is facing an inflection point in its growth.
Lockheed Martin — Lockheed Martin shares gained 1.52% after the company posted latest quarterly results. The defense company’s revenue came in at $18.99 billion, topping a Refinitiv forecast of $18.27 billion. Lockheed’s earnings per share also topped expectations.
AMD — The chip stock fell more than 2% in premarket after Bernstein downgraded the chipmaker to market perform from outperform. The Wall Street firm said the downgrade is due to the sliding computer and new parts demand in the inflationary environment.
● PMI Composite Flash
● 장전 상황
Lackluster earnings? Economic indicators pointing toward a recession? No problem. At least not so far. U.S. stock markets are green so far in this short-lived year, picking up some momentum in recent days. The Nasdaq, in particular, has shown strength, although after it’s bouncing after a dismal 2022, which saw many big tech stocks hammered, as well. Several tech companies, including Dow component Microsoft (which reports earnings after the bell Tuesday), are cutting thousands of jobs after a pandemic-fueled hiring spree in a bid to show investors they’re serious about cost cuts. Other companies on the earnings docket Tuesday: Verizon, Lockheed Martin, General Electric and Johnson & Johnson.
● Many New York Stock Exchange-listed stocks halted for a technical issue
Trading in dozens of stocks on the New York Stock Exchange was halted shortly after the market opened on Monday after an apparent technical issue.
The major stocks impacted included Morgan Stanley, Verizon, AT&T, Nike and McDonald’s, according to the NYSE’s website. Many stocks were shown to have abnormally large moves when the market opened, which may have triggered volatility halts.
● Google employees push for answers
Alphabet’s Google is facing numerous headaches, including questions about whether OpenAI’s ChatGPT has outflanked the company’s own AI initiatives. Google is also going through its biggest-ever wave of layoffs. CEO Sundar Pichai took a great deal of heat from employees during a companywide town hall Monday to discuss the challenges. Employees pressed for details about how Google leaders decided on whom to lay off and how. Pichai, CFO Ruth Porat and other executives also discussed bonus cuts for executives and where the company is targeting its hiring, among other issues.
● The path forward for Covid vaccines
Covid vaccines will likely need to be updated once a year, and most people will probably only need a shot a year, too, according to a proposed road map released by the Food and Drug Administration. The FDA’s recommendation is similar to its process for selecting flu shots each year. According to the briefing document released Monday, the FDA would pick the Covid strain for the vaccine during the spring, in time for updated shots to roll out in September, when kids are back and school and ahead of the holidays and virus-friendly winter months. Some, including elderly people and people with compromised immune systems, may need two shots a year, the FDA said.
